Breaking News Instant updates and real-time market news.

AWI

Armstrong World

$68.17

1.57 (2.36%)

16:41
11/06/18
11/06
16:41
11/06/18
16:41

Armstrong World initiates quarterly dividend

Armstrong World Industries announced that its board has approved the initiation of a dividend program under which the company will pay a regular quarterly cash dividend of 17.5c per share to shareholders. The first dividend will be paid on December 14 to shareholders of record as of the close of business on December 4.

  • 07

    Nov

AWI Armstrong World
$68.17

1.57 (2.36%)

10/02/18
GSCO
10/02/18
INITIATION
Target $70
GSCO
Neutral
Armstrong World initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Doug Clark started Armstrong World Industries with a Neutral rating and $70 price target. The analyst rolled out coverage on the Building Products sector with Neutral rating.
10/02/18
GSCO
10/02/18
INITIATION
Target $70
GSCO
Neutral
Armstrong World initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Doug Clark initiated Armstrong World with a Neutral and $70 price target.
11/02/18
KEYB
11/02/18
UPGRADE
KEYB
Overweight
Armstrong World upgraded to Overweight from Sector Weight at KeyBanc
11/02/18
KEYB
11/02/18
UPGRADE
Target $76
KEYB
Overweight
Armstrong World upgraded to Overweight from Sector Weight at KeyBanc
KeyBanc analyst Kenneth Zener upgraded Armstrong World to Overweight from Sector Weight with a $76 price target as steady earnings growth despite no volume gains in ceiling tiles, amid rising innovation, offers investors a cyclical balance of growth, with limited downside. In a research note to investors, Zener says he expects Armstrong's analyst day to provide further catalysts to his thesis.

TODAY'S FREE FLY STORIES

AMAT

Applied Materials

$35.03

1.44 (4.29%)

07:19
11/16/18
11/16
07:19
11/16/18
07:19
Recommendations
Applied Materials analyst commentary  »

Citi adds Applied…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BPMC

Blueprint Medicines

$52.33

-4.05 (-7.18%)

07:18
11/16/18
11/16
07:18
11/16/18
07:18
Recommendations
Blueprint Medicines analyst commentary  »

Blueprint Medicines data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

CUB

Cubic

$65.71

1.78 (2.78%)

07:18
11/16/18
11/16
07:18
11/16/18
07:18
Recommendations
Cubic analyst commentary  »

Cubic well positioned for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$64.59

1.09 (1.72%)

07:17
11/16/18
11/16
07:17
11/16/18
07:17
Periodicals
Citi says clients are adjusting supply chains due to trade war, CNBC reports »

Citi said their corporate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jan

  • 15

    Apr

  • 13

    Jul

SIGI

Selective Insurance

$64.11

1.81 (2.91%)

07:17
11/16/18
11/16
07:17
11/16/18
07:17
Initiation
Selective Insurance initiated  »

Selective Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

AGIO

Agios Pharmaceuticals

$67.26

3.54 (5.56%)

07:16
11/16/18
11/16
07:16
11/16/18
07:16
Hot Stocks
Agios Pharmaceuticals presents data from AG-881 study at SNO »

Agios Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

JCP

J.C. Penney

$1.37

0.14 (11.38%)

07:15
11/16/18
11/16
07:15
11/16/18
07:15
Downgrade
J.C. Penney rating change  »

J.C. Penney downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRU

Prudential

$92.49

-0.27 (-0.29%)

07:15
11/16/18
11/16
07:15
11/16/18
07:15
Recommendations
Prudential analyst commentary  »

Citi opens positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

WSM

Williams-Sonoma

$60.60

-1.16 (-1.88%)

07:14
11/16/18
11/16
07:14
11/16/18
07:14
Recommendations
Williams-Sonoma analyst commentary  »

Williams-Sonoma has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$202.65

5.43 (2.75%)

07:14
11/16/18
11/16
07:14
11/16/18
07:14
Recommendations
Nvidia analyst commentary  »

Nvidia price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

NVDA

Nvidia

$202.65

5.43 (2.75%)

07:12
11/16/18
11/16
07:12
11/16/18
07:12
Recommendations
Nvidia analyst commentary  »

Nvidia gaming channel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

SNY

Sanofi

$44.55

-0.53 (-1.18%)

07:12
11/16/18
11/16
07:12
11/16/18
07:12
Hot Stocks
Sanofi announces positive CHMP opinion for fexinidazole »

The European Medicines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 28

    Jan

  • 11

    Mar

  • 22

    Mar

  • 28

    Apr

BGNE

BeiGene

$126.85

2.29 (1.84%)

07:12
11/16/18
11/16
07:12
11/16/18
07:12
Hot Stocks
BeiGene presents preliminary data from pamiparib trial at SNO »

BeiGene announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 27

    Nov

  • 01

    Dec

  • 03

    Dec

NVDA

Nvidia

$202.65

5.43 (2.75%)

07:09
11/16/18
11/16
07:09
11/16/18
07:09
Recommendations
Nvidia analyst commentary  »

Nvidia 'finally…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

TRTX

TPG RE Finance

$19.83

-0.22 (-1.10%)

07:06
11/16/18
11/16
07:06
11/16/18
07:06
Hot Stocks
TPG RE Finance prices $1B Commercial Real Estate CLO »

TPG RE Finance Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STAF

Staffing 360 Solutions

$1.75

0.08 (4.79%)

07:05
11/16/18
11/16
07:05
11/16/18
07:05
Hot Stocks
Staffing 360 Solutions files documentation to regain Nasdaq compliance »

Staffing 360 Solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

07:05
11/16/18
11/16
07:05
11/16/18
07:05
General news
Treasury Market Outlook: »

Treasury Market Outlook:…

CLB

Core Laboratories

$84.29

2.945 (3.62%)

07:04
11/16/18
11/16
07:04
11/16/18
07:04
Upgrade
Core Laboratories rating change  »

Core Laboratories…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEB

Pebblebrook Hotel

$35.26

0.605 (1.75%)

, LHO

LaSalle Hotel

$34.19

0.44 (1.30%)

07:04
11/16/18
11/16
07:04
11/16/18
07:04
Hot Stocks
Pebblebrook Hotel says 'pleased' with ISS, Glass Lewis recommendations »

Pebblebrook Hotel Trust…

PEB

Pebblebrook Hotel

$35.26

0.605 (1.75%)

LHO

LaSalle Hotel

$34.19

0.44 (1.30%)

BX

Blackstone

$32.50

-0.41 (-1.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

CASI

Casi Pharmaceuticals

$3.50

0.17 (5.11%)

07:04
11/16/18
11/16
07:04
11/16/18
07:04
Hot Stocks
Casi Pharmaceuticals to build GMP Manufacturing Site In Wuxi, China »

CASI Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRMW

Primo Water

07:04
11/16/18
11/16
07:04
11/16/18
07:04
Upgrade
Primo Water rating change  »

Primo Water upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$99.62

-1.96 (-1.93%)

07:04
11/16/18
11/16
07:04
11/16/18
07:04
Recommendations
Walmart analyst commentary  »

Walmart price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAH

Cardinal Health

$57.62

0.315 (0.55%)

07:03
11/16/18
11/16
07:03
11/16/18
07:03
Downgrade
Cardinal Health rating change  »

Cardinal Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

VIAB

Viacom

$31.87

0.07 (0.22%)

, VIA

Viacom

$36.09

0.76 (2.15%)

07:03
11/16/18
11/16
07:03
11/16/18
07:03
Earnings
Viacom reports Q4 adj. EPS 99c, consensus 95c »

Reports Q4 revenue…

VIAB

Viacom

$31.87

0.07 (0.22%)

VIA

Viacom

$36.09

0.76 (2.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 16

    Nov

  • 04

    Dec

RFP

Resolute Forest

$12.07

-0.09 (-0.74%)

07:03
11/16/18
11/16
07:03
11/16/18
07:03
Hot Stocks
Resolute Forest names Remi Lalonde as CFO, succeeding Jo-Ann Longworth »

Resolute Forest Products…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.